Compugen

Compugen Gross Profit

The Gross Profit of Compugen (CGEN) as of Oct 8, 2026 is 63.51 M USD. In the previous year, Gross Profit was 19.93 M USD — a change of 218.62% (higher).

Gross Profit

63.51 MUSD

YoY

218.62%

Last updated:

Gross Profit of Compugen is 2025 63.51 M USD. Gross Profit of Compugen was 2024 19.93 M USD. It decreases by 218.62% higher compared to the previous year.

The Compugen Gross Profit history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Gross Profit
Date
Gross Profit
Jan 1, 2018
16.77 M USD
Jan 1, 2019
-989,000.00 USD
Jan 1, 2020
1.94 M USD
Jan 1, 2021
5.32 M USD
Jan 1, 2022
6.53 M USD
Jan 1, 2023
31.46 M USD
Jan 1, 2024
19.93 M USD
Jan 1, 2025
63.51 M USD
The Compugen Gross Profit history
YEARGross ProfitYoY
63.51 MUSD+218.62%
19.93 MUSD-36.63%
31.46 MUSD+382.07%
6.53 MUSD+22.65%
5.32 MUSD+174.23%
1.94 MUSD-296.16%
-989,000.00USD-105.90%
16.77 MUSD-1,152.48%
-1.59 MUSD-425.77%
489,000.00USD-93.60%
7.64 MUSD-15.28%
9.02 MUSD+767.60%
1.04 MUSD+2,436.59%
41,000.00USD-104.83%
-848,000.00USD-195.17%
891,000.00USD+256.40%
250,000.00USD-24.47%
331,000.00USD+83.89%
180,000.00USD-13.88%
209,000.00USD—
Access this data via the Eulerpool API

Compugen Revenue

Compugen Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2023
33.46 M USD
-12.99 M USD
-18.75 M USD
Jan 1, 2024
27.86 M USD
-14.89 M USD
-14.23 M USD
Jan 1, 2025
72.76 M USD
31.33 M USD
35.34 M USD
Jan 1, 2026 (e)
10.20 M USD
-31.31 M USD
-26.27 M USD
Jan 1, 2027 (e)
16.05 M USD
-36.18 M USD
-25.89 M USD
Jan 1, 2028 (e)
30.88 M USD
-23.81 M USD
-23.83 M USD
Jan 1, 2029 (e)
27.03 M USD
-35.44 M USD
-35.46 M USD
Jan 1, 2030 (e)
36.11 M USD
-28.12 M USD
-28.14 M USD

Compugen Margins

Compugen stock margins

The Compugen margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Compugen. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Compugen.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2023
94.01 %
-38.83 %
-56.05 %
Jan 1, 2024
71.54 %
-53.44 %
-51.07 %
Jan 1, 2025
87.29 %
43.05 %
48.57 %
Jan 1, 2026 (e)
87.29 %
-307.08 %
-257.62 %
Jan 1, 2027 (e)
87.29 %
-225.47 %
-161.35 %
Jan 1, 2028 (e)
87.29 %
-77.10 %
-77.17 %
Jan 1, 2029 (e)
87.29 %
-131.14 %
-131.22 %
Jan 1, 2030 (e)
87.29 %
-77.88 %
-77.94 %

Compugen Stock analysis

What does Compugen do? Compugen Ltd is an Israeli biotechnology company focused on the development of therapeutics and diagnostic products. It was founded in 1993 and is headquartered in Tel Aviv. Compugen is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Compugen stock

Gross Profit of Compugen is 63.51 M USD in 2025.

Gross Profit of Compugen changed from 19.93 M USD to 63.51 M USD, representing a 218.62% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Gross Profit Compugen since 2006 – with annual values, charts, and detailed analysis.

Gross Profit is the revenue remaining after deducting the cost of goods sold. It shows how efficiently a company uses its resources to produce goods or services.

Gross Profit's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Gross Profit's Compugen historically and in real time.

Access this data via the Eulerpool API

Income Statement — Compugen

All Key Metrics — Compugen